Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TOVX
TOVX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TOVX News
Theriva Biologics Advances VCN-01 to Phase 3 Clinical Trial
6d ago
Newsfilter
Theriva Biologics Reports FY GAAP EPS of -$2.08
Mar 12 2026
seekingalpha
Small-Cap Acquisitions Drive Market Gains
Feb 19 2026
Newsfilter
Etsy Sells Depop to eBay for $1.2 Billion
Feb 19 2026
Benzinga
Theriva Biologics Receives EMA Support for Phase 3 Trial of VCN-01
Dec 29 2025
Benzinga
Theriva Receives EMA Approval for Phase 3 Trial of VCN-01 in Metastatic PDAC
Dec 29 2025
Globenewswire
Theriva Receives EMA Approval for Phase 3 Trial of VCN-01 in Metastatic PDAC
Dec 29 2025
Newsfilter
Theriva Biologics: Overview of Q3 Earnings
Nov 12 2025
Yahoo Finance
Theriva Biologics Addresses Uncommon Market Activity
Oct 24 2025
Newsfilter
Stock Market Update: Nasdaq and Dow Futures Rise on Third Day of Shutdown—Focus on Rumble, Rigetti, and Kodiak
Oct 03 2025
Benzinga
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer
May 27 2025
Newsfilter
Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results
May 14 2025
Newsfilter
Theriva Biologics Announces Closing of $7.5 Million Public Offering
May 08 2025
Newsfilter
This Coty Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
May 08 2025
Benzinga
Theriva Biologics announces pricing of $7.5M public offering
May 07 2025
SeekingAlpha
Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company's Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Mar 31 2025
Newsfilter
Show More News
